Organization: Health Canada
Year: 2024
Month: December
Request Number: A-2024-000644
Request Summary: With respect to generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022- 06-22 for the medicinal ingredient mesalazine, a screen shot from Health Canada’s Drug Submission Tracking System (DSTS) for this Abbreviated New Drug Submission (ANDS).
Disposition: Disclosed in part
Number of pages: 1